A California-based biotech company saw its shares soar on Wednesday, a day following the company’s Q4 earnings announcement. With analysts expecting a net loss of $0.16 per...

To read the full story on AllPennyStocks.com, click here.

Heron Therapeautics (NASDAQ:HRTX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Heron Therapeautics.
Heron Therapeautics (NASDAQ:HRTX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Heron Therapeautics.